Practical manufacturing operations

Batch Review and Release Readiness Workbook

30 evidence controls across five decision gates. Assess a defined batch and destination market—not an undefined claim of whole-site compliance.

Start the assessment →

How to use this workbook

Identify the product, batch, site and destination market and assessment date.
Assess each applicable control against current objective evidence. Record a reference, accountable owner and due date for any gap.
Justify every “Not applicable” decision and obtain appropriate review. Excluded controls reduce the score denominator.
Resolve relevant blockers before progression and record the authorized decision in your approved system.
Export your assessment for review. CSV and print use the currently visible controls; reset filters for a complete export.

Important: The percentage is a checklist completion indicator, not a GMP certificate, batch release, electronic signature or risk-weighted compliance rating. Even 100% requires independent review of the evidence. Legal requirements and identity or Quality-release failures cannot be waived by this tool.

Progress is stored only in this browser and may be lost if browser data is cleared. This is not a validated GxP record system or secure document repository. Use non-confidential record references, keep controlled records in your approved system and retain an export. No registration is required.

Read the batch review and release guide and primary references →

Interactive batch review and release assessment

Make the evidence ready for an authorized disposition decision.

Define the assessment scope, assess each control, record the available evidence or next action, and use the gate view to expose what still prevents safe execution. Entries remain in this browser. “Ready” requires current, objective evidence—not an expected future action.

0%evidence ready

Assessed: 0/30
Ready: 0
In progress: 0
Open gaps: 0
Gate blockers unresolved: 30

Product / batchSite / destination marketRecord / review referencesAssessment dateAssessment owner

Establish review scope0/6 ready

Review executed operations0/6 ready

Review laboratory evidence0/6 ready

Resolve exceptions0/6 ready

Authorized disposition0/6 ready

30 of 30 readiness controls shown

Framework reviewed 3 November 2026. Your context, notes and status remain only in this browser.

Control / gate	Readiness control	Owner / applicability	Criticality	Minimum evidence	Primary basis	Your assessment
ID-01Batch and regulatory identityG1 · Establish review scope	Batch identity reconciled Product, strength, dosage form, bulk and packaging batch numbers and quantities agree across records.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Batch genealogy and controlled master records	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
ID-02Batch and regulatory identityG1 · Establish review scope	Market authorization confirmed Manufacturing site, formula, pack and destination market match the effective authorization.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Regulatory market/pack verification	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
ID-03Batch and regulatory identityG1 · Establish review scope	Correct record versions used Issued manufacturing and packaging instructions were effective for execution; changes are authorized.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Master version and issuance history	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
ID-04Batch and regulatory identityG1 · Establish review scope	Complete record set available Pages, attachments, printouts and relevant electronic records are accounted for.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Record index and attachment reconciliation	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
ID-05Batch and regulatory identityG1 · Establish review scope	Review responsibilities defined Production, QC, QA and final disposition roles have current delegated authority.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Approved review procedure and authorization list	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
ID-06Batch and regulatory identityG1 · Establish review scope	Batch scope includes outsourced steps Contract manufacturing, testing and storage records are available and responsibilities are defined.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Quality agreements and partner confirmations	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
MFG-01Manufacturing and packaging reviewG2 · Review executed operations	Materials traceable and released Actual lots, quantities and release status support the material used, including substitutions or returns.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Executed dispensing and addition records	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
MFG-02Manufacturing and packaging reviewG2 · Review executed operations	Process chronology reconstructed Times, sequence, parameters and signatures demonstrate execution against approved instructions.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Reviewed batch record and source data	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
MFG-03Manufacturing and packaging reviewG2 · Review executed operations	In-process controls acceptable Required checks were performed at required stages; deviations and atypical results are assessed.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	IPC results and exception references	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
MFG-04Manufacturing and packaging reviewG2 · Review executed operations	Yield and quantities reconciled Stage yields and packaging quantities use verified calculations; unexplained discrepancies are investigated.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Yield calculation and reconciliation	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
MFG-05Manufacturing and packaging reviewG2 · Review executed operations	Equipment and utilities fit for use Cleaning, calibration, maintenance, utility and environmental status at execution are assessed.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Time-linked equipment and utility records	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
MFG-06Manufacturing and packaging reviewG2 · Review executed operations	Packaging identity and clearance verified Correct artwork, batch coding, expiry, market and line clearance are documented.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Packaging record and retained specimens	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
QC-01Laboratory and data reviewG3 · Review laboratory evidence	Required tests complete All required batch tests use effective specifications and methods; results are independently reviewed.	QC / QADefined batch and market; justify exclusions	Gate blocker	Approved laboratory package and specification	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
QC-02Laboratory and data reviewG3 · Review laboratory evidence	Sampling representative Sampling, custody, sample identity and any subcontract testing are traceable.	QC / QADefined batch and market; justify exclusions	Gate blocker	Sampling plan and chain of custody	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
QC-03Laboratory and data reviewG3 · Review laboratory evidence	Original data reviewed Relevant raw data, calculations, integrations and audit trails support reported results.	QC / QADefined batch and market; justify exclusions	Gate blocker	Raw-data review and audit-trail references	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
QC-04Laboratory and data reviewG3 · Review laboratory evidence	OOS investigation resolved An original failing result is not discarded solely because a retest passes; scientific disposition is documented.	QC / QADefined batch and market; justify exclusions	Gate blocker	OOS investigation and Quality conclusion	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
QC-05Laboratory and data reviewG3 · Review laboratory evidence	OOT and atypical trends assessed Within-limit results that are unusual have appropriate batch and broader impact assessment.	QC / QADefined batch and market; justify exclusions	Gate blocker	Trend comparison and investigation assessment	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
QC-06Laboratory and data reviewG3 · Review laboratory evidence	Certificate matches approved results Certificate values, units, limits and batch identity agree with approved results.	QC / QADefined batch and market; justify exclusions	Gate blocker	Verified certificate of analysis	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
EXC-01Exceptions and impact assessmentG4 · Resolve exceptions	All linked deviations identified Reconcile batch references with deviation, maintenance and laboratory logs to detect missing events.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Cross-system exception register	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
EXC-02Exceptions and impact assessmentG4 · Resolve exceptions	Product impact resolved Critical uncertainty about identity, strength, quality, purity or compliance remains a hold condition.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Approved scientific impact assessment	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
EXC-03Exceptions and impact assessmentG4 · Resolve exceptions	Change control conditions met Applicable changes and regulatory approvals are effective and implementation prerequisites complete.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Change record and regulatory assessment	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
EXC-04Exceptions and impact assessmentG4 · Resolve exceptions	Validation status acceptable Batch execution fits validated conditions; any additional validation or hold requirements are met.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Validation status and batch-specific conditions	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
EXC-05Exceptions and impact assessmentG4 · Resolve exceptions	CAPA timing justified Distinguish actions required before release from longer-term prevention; document authority, due dates and interim controls.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	CAPA prerequisite assessment	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
EXC-06Exceptions and impact assessmentG4 · Resolve exceptions	Other affected batches considered Assess related lots, products and distributed batches where evidence suggests wider impact.	Responsible department / QADefined batch and market; justify exclusions	Gate blocker	Scope assessment and escalation record	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
DIS-01Disposition and distribution controlG5 · Authorized disposition	Independent review complete Required Production, QC and Quality reviews are completed by authorized personnel.	Authorized release person / QADefined batch and market; justify exclusions	Gate blocker	Review checklist and controlled signatures	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
DIS-02Disposition and distribution controlG5 · Authorized disposition	Storage history acceptable Finished batch storage and any transport excursions are assessed before disposition.	Authorized release person / QADefined batch and market; justify exclusions	Gate blocker	Environmental and excursion review	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
DIS-03Disposition and distribution controlG5 · Authorized disposition	Retention and stability duties met Required samples and applicable stability commitments are documented.	Authorized release person / QADefined batch and market; justify exclusions	Gate blocker	Sample inventory and stability enrollment	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
DIS-04Disposition and distribution controlG5 · Authorized disposition	Decision recorded unambiguously Authorized release, hold or rejection identifies batch, scope, date, reasons and applicable market.	Authorized release person / QADefined batch and market; justify exclusions	Gate blocker	Controlled disposition record	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
DIS-05Disposition and distribution controlG5 · Authorized disposition	Premature dispatch prevented Physical/electronic blocks prevent supply until authorized release; status handover is verified.	Authorized release person / QADefined batch and market; justify exclusions	Gate blocker	Warehouse status and release notification	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action
DIS-06Disposition and distribution controlG5 · Authorized disposition	Post-decision traceability maintained Distribution, retention and new-information escalation support recall and retrospective impact assessment.	Authorized release person / QADefined batch and market; justify exclusions	Gate blocker	Distribution linkage and escalation procedure	See guide: applicable national GMP, WHO GMP and market-specific requirements	StatusEvidence or next action

Decision rule: this tool never authorizes release. Unresolved release prerequisites require a hold and authorized assessment. A score or risk assessment cannot waive legal requirements. Justify each “Not applicable” decision and document final disposition in the approved quality system.

Connect the decisions

Educational planning aid. Adapt to applicable requirements and approved procedures.